BIT 2.70% 3.8¢ biotron limited

not true. According to PhRMA (“the process behind new...

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    not true. According to PhRMA (“the process behind new medicines”, 2015, online) , average clinical development time (from phases1 to 3) is around 6-7 years. Total time discovery to approval 10 years. So you’re well off the mark sorry. But I guess phrma data based on companies that know what they’re doing and are actually doing stuff. 15-20 years is probably about right when you have a company that’s a scientist’s hobby with job for life md.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $68.85K 1.794M

Buyers (Bids)

No. Vol. Price($)
2 150000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 349950 3
View Market Depth
Last trade - 15.10pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.